Dark Forest Capital Management’s ImmunityBio IBRX Stock Holding History

Dark Forest Capital Management’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$152K	Buy	+19,781	New	+$135K	0.01%	750
2025 Q1	–	Sell	-25,144	Closed	-$64.4K	–	1325
2024 Q4	$64.4K	Buy	+25,144	New	+$105K	0.01%	871
2024 Q2	–	Sell	-45,433	Closed	-$244K	–	767
2024 Q1	$244K	Buy	+45,433	New	+$206K	0.04%	539
2023 Q3	–	Sell	-203,659	Closed	-$566K	–	1179
2023 Q2	$566K	Buy	203,659 +203,634	+814,536%	+$576K	0.05%	586
2023 Q1	$46	Buy	+25	New	+$78	﹤0.01%	1132
2022 Q1	–	Sell	-46	Closed	–	–	1505
2021 Q4	$0	Buy	+46	New	+$346	﹤0.01%	1587
2021 Q3	–	Sell	-3,692	Closed	-$53K	–	1392
2021 Q2	$53K	Buy	+3,692	New	+$61K	0.02%	438

Other funds holding IBRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Dark Forest Capital Management's IBRX Position: Q1 2026 in Review

Dark Forest Capital Management opened a new position in ImmunityBio (IBRX) in Q1 2026: 19,781 shares worth $152K. The stake represents 0.01% of the portfolio and ranks #750 among its holdings. This is a return to the name: Dark Forest Capital Management previously reported a position in IBRX as recently as Q4 2024.

Dark Forest Capital Management first reported a position in IBRX in Q2 2021 and has held it in 7 quarters since. The position peaked at $566K in Q2 2023. 386 funds tracked by Wall St. Rank hold IBRX as of Q1 2026.

Dark Forest Capital Management held 19,781 shares of ImmunityBio worth $152K as of Q1 2026.
ImmunityBio was a new Dark Forest Capital Management position in Q1 2026.
ImmunityBio made up 0.01% of Dark Forest Capital Management's portfolio in Q1 2026, its #750 holding.
Dark Forest Capital Management first reported a position in ImmunityBio in Q2 2021 and has held it in 7 quarters since.
Dark Forest Capital Management's ImmunityBio position peaked at $566K in Q2 2023.
386 funds tracked by Wall St. Rank held ImmunityBio as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.